170 related articles for article (PubMed ID: 36354728)
21. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
[TBL] [Abstract][Full Text] [Related]
22. [Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular].
Ruiz-González JF; Guevara-Gutiérrez E; Hernández-Torres M; Ledesma GS; Tlacuilo-Parra A
Cir Cir; 2018; 86(5):417-422. PubMed ID: 30226497
[TBL] [Abstract][Full Text] [Related]
23. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
24. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
25. Immunocryosurgery - an effective combinational modality for Bowen's disease.
Gaitanis G; Bassukas ID
Dermatol Ther; 2016 Sep; 29(5):334-337. PubMed ID: 27272913
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon.
Sánchez V; Carpio E; Fardales VE; Martínez B; Arias AI; Brito E; Bermudez N; Rodríguez Y
An Bras Dermatol; 2024; 99(3):391-397. PubMed ID: 38383261
[TBL] [Abstract][Full Text] [Related]
27. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
28. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
Spencer JM; Tannenbaum A; Sloan L; Amonette RA
Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
[TBL] [Abstract][Full Text] [Related]
29. Intralesional cryosurgery for the treatment of basal cell carcinoma of the lower extremities in elderly subjects: a feasibility study.
Har-Shai Y; Sommer A; Gil T; Krausz J; Gal-Or N; Mettanes I; Lavi I; Eyal N; Brizgalin L; Taran A; Har-Shai L; Elmalach I
Int J Dermatol; 2016 Mar; 55(3):342-50. PubMed ID: 26749491
[TBL] [Abstract][Full Text] [Related]
30. Cryosurgery for Facial and Scalp Lesions of Basal Cell Carcinoma: A Study in 29 Elderly Patients.
Savant S; Savant S; Sehgal VN
Skinmed; 2017; 15(5):357-364. PubMed ID: 29139363
[TBL] [Abstract][Full Text] [Related]
31. A single-centre retrospective comparison of immunocryosurgery with standard surgical excision for the treatment of non-superficial, head and neck basal cell carcinoma.
Gaitanis G; Seretis K; Zampeta A; Spyridonos P; Bassukas ID
J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):e134-e136. PubMed ID: 37641949
[No Abstract] [Full Text] [Related]
32. Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial.
Backman EJ; Polesie S; Berglund S; Gillstedt M; Sjöholm A; Modin M; Paoli J
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1758-1765. PubMed ID: 35543079
[TBL] [Abstract][Full Text] [Related]
33. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
34. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules.
Mallon E; Dawber R
Dermatol Surg; 1996 Oct; 22(10):854-8. PubMed ID: 9246168
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
[TBL] [Abstract][Full Text] [Related]
36. A retrospective comparative study of outcome with surgical excision and repair versus nonsurgical and ablative treatments for basal cell carcinoma.
Mahajan S; Kalaivani M; Sethuraman G; Khaitan BK; Verma KK; Gupta S
Indian J Dermatol Venereol Leprol; 2021; 87(3):348-356. PubMed ID: 33666033
[TBL] [Abstract][Full Text] [Related]
37. The combined effect of CO
El-Khalawany M; Saudi WM; Ahmed E; Mosbeh A; Sameh A; Rageh MA
J Cosmet Dermatol; 2022 May; 21(5):2049-2055. PubMed ID: 34333841
[TBL] [Abstract][Full Text] [Related]
38. Implication of wide surgical excision in minimizing positive margins and consequential secondary excision - a retrospective comparative study involving 106 basal cell carcinoma cases.
Kundnani NR; Tirziu RV; Borza C; Tirziu C; Sharma A; Rosca CI; Baderca F; Paul C; Solovan CS; Blidisel A
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4283-4288. PubMed ID: 34227063
[TBL] [Abstract][Full Text] [Related]
39. Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream.
Mirza B; De'Ambrosis B
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():16-8. PubMed ID: 14616806
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
Wang H; Xu Y; Shi J; Gao X; Geng L
Photodermatol Photoimmunol Photomed; 2015 Jan; 31(1):44-53. PubMed ID: 25377432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
